Clinical Trials Logo

Headache clinical trials

View clinical trials related to Headache.

Filter by:

NCT ID: NCT03928496 Completed - Clinical trials for Post-Traumatic Headache

Abobotulinumtoxina Efficacy in Post-Traumatic Headache

Start date: August 1, 2013
Phase: Phase 4
Study type: Interventional

This study will evaluate the efficacy of abobotulinumtoxina on Veterans with post-traumatic headache

NCT ID: NCT03919630 Completed - Clinical trials for Cervicogenic Headache

Mobilization Versus Manipulation for the Treatment of Cervicogenic Headaches

Start date: May 1, 2019
Phase: N/A
Study type: Interventional

There is currently a gap within the literature as to the effects of a thrust versus non-thrust mobilizations techniques specifically to the upper cervical spine C0-C3 along with home exercise program to help reduce frequency and intensity of cervicogenic headaches. Therefore, the purpose of this study is to examine the effectiveness of in treating headaches using non-thrust or thrust mobilizations in addition to postural corrective exercises on patient outcomes measures.

NCT ID: NCT03910088 Completed - Clinical trials for Post-Dural Puncture Headache

Pregabalin Versus Hydrocortisone for Postdural Puncture Headache After Spinal for Cesarean

PDPH
Start date: April 20, 2019
Phase: Phase 4
Study type: Interventional

Postdural puncture headache (PDPH) is a common complication after spinal anesthesia. The role of pregabalin and hydrocortisone in the treatment of PDPH is unclear. The aim of this work is to assess and compare the efficacy of both drugs in severe cases of PDPH after spinal anesthesia for elective cesarean section.

NCT ID: NCT03908424 Completed - Clinical trials for Parturient Who Gave Informed Consent to Participation in the Study

Chronic Headache and Chronic Backache Following Unintentional Dural Puncture at Delivery Room.

Start date: May 1, 2019
Phase:
Study type: Observational

he study is a telephone questionnaire. The study will include 400 women, 100 in each group. OBJECTIVE: To investigate the prevalence of chronic and chronic back pain following PDPH accidental dural puncture during epidyral analgesia for delivery. 1. Parturients who gave birth to a normal birth and did not receive epidural anesthesia. 2. Parturients who gave birth to a normal birth with epidural anesthesia without an unintentional dural puncture. 3. Parturients who gave birth to a normal birth with epidural anesthesia and had an unintentional dural puncture, these women were treated conservatively. 4. Parturients who had a normal birth with epidural anesthesia and had an unintentional dural puncture and were treated with a blood patch following PDPH.

NCT ID: NCT03896256 Completed - Clinical trials for Migraine Headache With Intractable Migraine

Ketamine for Refractory Chronic Migraine: a Pilot Study

Start date: March 22, 2019
Phase: Early Phase 1
Study type: Interventional

Ketamine is a drug used for anesthesia but at low doses it is a very effective pain reliever in several chronic conditions. Preliminary studies have shown that ketamine might be effective for patients with refractory chronic migraine, which is a severe type of headache for which patients usually have tried and failed many medications and can cause severe disability to their lives. This study will evaluate ketamine prospectively when given to patients who have "failed" an initial inpatient treatment.

NCT ID: NCT03890393 Completed - Clinical trials for Myofascial Trigger Points

A Clinical Observation on Electrophysiology in Headache Patients With Myofascial Trigger Points

Start date: January 1, 2018
Phase:
Study type: Observational

Through an observational, cross-sectional study, muscle activity was compared among 21 subjects with episodic headache, 17 subjects with chronic headache and 17 age-matched healthy controls. Muscle activity was bilaterally tested with needle electromyography at rest status, targeting at myofascial trigger points (MTrPs) in the frontal, temporal, sternocleidomastoid (SCM), splenius capitis, splenius cervicis and trapezius of each subject. Headache characteristics (intensity, frequency and duration), McGill Pain Questionnaire (MPQ) and Digital Span (DS) scales were secondary outcomes. The correlation between muscle activity and headache characteristics was also analyzed. This study provides preliminary evidence of the relationship between muscle and the chronicity of headache.

NCT ID: NCT03887325 Completed - Headache, Migraine Clinical Trials

The Effects of Maxipost (BMS 204352) on Cerebral Hemodynamic and Headache in Healthy Volunteers and Migraine Patients

Start date: April 1, 2019
Phase: N/A
Study type: Interventional

It is not previously investigated whether, there is a correlation between potassium channels and migraine, so it is unclear whether, this signaling pathway through potassium channels has an impact on migraine pathophysiology. Maxipost (BMS 204352) is a vasoactive molecule that causes vasodilation via the big calcium dependent potassium (BKCa) channel signaling pathway. Maxipost decreases the blood pressure and maxipost infusion causes headache in healthy volunteers. A possible coherence between maxipost and headache/migraine in healthy volunteers and migraine patients is yet to be investigated. The present study aims to clarify a possible coherence between maxipost and headache/migraine and it will help to shed light on the importance of potassium channels in migraine. In general, the study will contribute to a greater understanding of migraine pathogenesis and possibly lead to development of specific migraine treatment.

NCT ID: NCT03881644 Completed - Clinical trials for Migraine Without Aura

PACAP38 Induced Headache, Migraine and Flushing in Patients With Migraine

Start date: July 17, 2018
Phase: N/A
Study type: Interventional

The aim is to investigate the incidence of headache, migraine attacks and flushing after pituitary adenylate cyclase-activating peptide-38 (PACAP38) with and without treatment with sumatriptan in patients with migraine

NCT ID: NCT03878784 Completed - Rosacea Clinical Trials

PACAP38 Induced Headache and Rosacea-like Symptoms in Patients With Rosacea

Start date: November 12, 2018
Phase: N/A
Study type: Interventional

The investigators aim is to investigate the incidence of headache and rosacea-like flushing after pituitary adenylate cyclase-activating peptide-38 (PACAP38) with and without treatment with sumatriptan in patients with rosacea

NCT ID: NCT03862638 Completed - Clinical trials for Chronic Tension-Type Headache

Yoga Therapy for Chronic Tension-Type Headache

Start date: April 10, 2010
Phase: N/A
Study type: Interventional

Chronic tension headache represents a considerable social burden in terms of both costs to the health services and also the costs of lost productivity. Episodic tension-type headache can be treated with rest and analgesics, while chronic tension-type headache demands a more fundamental treatment. Effectiveness of yoga therapy in the management of chronic tension type headache is limited. In this study, yoga therapy was used to explore its effect on chronic tension-type headache.